🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Common Wart

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine NCT05371353n/a2 sites📍 Yangchun📍 Mianyang Shanghai Bovax Biotechnology Co., Ltd. Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart NCT06737406NA1 site📍 Sari Mazandaran University of Medical Sciences · Tests: Topical 5% fluorouracil cream, Topical 0.005% calcipotriol ointment, Placebo, Placebo Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04422366Phase 31 site📍 Liuzhou Shanghai Bovax Biotechnology Co., Ltd. · Tests: 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARD… Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir NCT07448844Phase 42 sites📍 Rawalpindi📍 Islamabad Riphah International University · Tests: Intralesional Acyclovir, Intralesional Vitamin D3 Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts NCT03977753Phase 46 sites📍 Bouge📍 Ghent📍 Oisquercq Labo'Life · Tests: 2LVERU® or 2LVERU® JUNIOR, Placebo To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years NCT06756269Phase 21 site📍 Nanning Shanghai Bovax Biotechnology Co., Ltd. · Tests: Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine, Placebo, 9-HPV vaccine Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) NCT07457918Phase 312 sites📍 Saint Augustine📍 Plainfield📍 New Orleans Verrica Pharmaceuticals Inc. · Tests: Cantharidin Liquid Nitrogen Cryotherapy Versus CO₂ Laser for Palmoplantar Warts NCT07881198NA1 site📍 Multan Bkahtawar Amin Medical and Dental College Multan · Tests: Liquid Nitrogen Cryotherapy, Carbon Dioxide (CO₂) Laser Therapy Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) NCT07637734Phase 320 sites📍 San Diego📍 Jacksonville📍 Sweetwater Verrica Pharmaceuticals Inc. · Tests: VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy